2016, FDA, Fraud and Regulatory Compliance - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2016

FDA

Fraud

Regulatory Compliance

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

DECEMBER 29, 2023

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. Monsanto Co. ,

FDA

FDA US Department of Health and Human Services COVID-19 Informed Consent

Another Decision Admitting Evidence of FDA §510(k) Clearance

Drug & Device Law

JUNE 5, 2023

April 21, 2023), became the latest decision to follow what used to be (before the Pelvic Mesh litigation used the law in this area as a settlement tool) the overwhelming majority rule, that FDA decisions to allow products to be marketed – including §510(k) clearance – were routinely admissible. The Kelley court agreed with the defendant.

FDA

FDA Regulatory Compliance Compliance Fraud

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Another Decision Admitting Evidence of FDA §510(k) Clearance

Stay Connected